Purchase Order 36C24225P1097
Award Date
6/11/25
Potential Completion Date
8/1/25
Potential Value
$10K
Federal Agency
Veterans Integrated Service Network 2
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract, valued at $10,122.32, is for the delivery of DUOPA, a medication used to treat Parkinson's disease. The contract has an ultimate completion date of June 20, 2025 and was awarded on March 21, 2025. Accredo Health Group, Inc. is a key distributor of complex...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of the specialty pharmaceutical DUOPA. The $10,122.32 contract has a completion date of May 7, 2025 and was awarded on February 7, 2025 with no set-aside designation. Accredo Health Group, Inc., a subsidiary of Express Scripts, is a key distributor of complex and high-value medications, primarily...
This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
This is a $32,078.04 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a specialty pharmacy services provider. The contract, which does not have a set-aside designation, is for the delivery of various high-value medications to support the VA's healthcare services for veterans, including treatments for conditions such as pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders....
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the express delivery of second quarter pharmacy orders with a ceiling value of $86,938.57 and a completion date of July 24, 2017. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract, valued at $160,429.83, is for the delivery of the medication Uptravi 1600mcg, which is used to treat pulmonary arterial hypertension (PAH). The contract is part of the VA's efforts to provide critical medications to veterans through its Veterans...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit specialty pharmacy company. The contract is for a 180-day supply of the medication Uptravi 600mcg, with a ceiling value of $78,557.34. The contract is not designated as a set-aside. Accredo Health Group, Inc. is a key distributor of complex and high-value medications to the VA's Veterans Integrated Service Networks (VISNs), with a focus on drugs...
This federal contract award, valued at $80,409.58, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company and subsidiary of Express Scripts. The contract is a firm fixed-price purchase order for the delivery of 9 pharmacy orders across multiple VISN locations, including medications to treat conditions such as pulmonary arterial hypertension, neuropathic lysosomal storage...
This firm fixed-price purchase order, valued at $8,906.37, was awarded by the National Institutes of Health (NIH) Clinical Center to Accredo Health Group, Inc., a specialty pharmacy services provider. The contract is for the delivery of specific medications, such as Uptravi, Tyvaso, and Oxervate, to support treatment programs for the Veterans Health Administration (VHA). Accredo is a subsidiary of Express Scripts and has an established role as a key pharmaceutical distributor in the VA's...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) to Accredo Health Group, Inc., a for-profit pharmaceutical distributor. The contract, valued at $76,986.72, is for the delivery of the specialty medication "EMERGENCY LUMRYZ 9GM" with a period of performance ending on September 30, 2025. Accredo Health Group, Inc. is a subsidiary of Express Scripts and a key provider of complex and high-value...